Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Insider Filings - KERINS PATRICK J
Last Updated 
27-Jan-16
Enter symbol:
symbol lookup

 

EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search

KERINS PATRICK J: Declared Holdings
Company/RelationshipReportedShares  Ownership
Adaptimmune Therapeutics plc
Beneficial Owner (10% or more)
NasdaqGS:ADAP
(historical quotes, profile, other insiders)
1-Jan-1659,269,000  Indirect
Ardelyx, Inc.
Beneficial Owner (10% or more)
NasdaqGM:ARDX
(historical quotes, profile, other insiders)
23-Dec-14
13-Jan-16
241
   7,988,893
7,989,134
  Direct
  Indirect  
  Total
Box, Inc. Class A Common Stock
Beneficial Owner (10% or more)
NYSE:BOX
(historical quotes, profile, other insiders)
28-Jan-150  Indirect
Cerecor Inc.
Beneficial Owner (10% or more)
NasdaqCM:CERCU
(historical quotes, other insiders)
20-Oct-15594,245  Indirect
CHAMPIONS ONCOLOGY
Beneficial Owner (10% or more)
NasdaqCM:CSBR
(historical quotes, profile, other insiders)
11-Mar-1518,750,000  Indirect
ChannelAdvisor Corporation Comm
Director
NYSE:ECOM
(historical quotes, profile, other insiders)
1-Jul-15
14-Dec-15
22,092
   0
22,092
  Direct
  Indirect  
  Total
INTERLEUKIN GENETICS
Beneficial Owner (10% or more)
Other OTC:ILIU
(historical quotes, profile, other insiders)
23-Dec-1435,298,087  Indirect
Loxo Oncology, Inc.
Beneficial Owner (10% or more)
NasdaqGM:LOXO
(historical quotes, profile, other insiders)
6-Aug-141,789,420  Indirect
Mirna Therapeutics, Inc.
Beneficial Owner (10% or more)
NasdaqGM:MIRN
(historical quotes, profile, other insiders)
6-Oct-152,971,517  Indirect
Roka Bioscience, Inc.
Beneficial Owner (10% or more)
NasdaqGM:ROKA
(historical quotes, profile, other insiders)
22-Jul-143,216,810  Indirect
Sunesis Pharmaceuticals, Inc.
Beneficial Owner (10% or more)
NasdaqCM:SNSS
(historical quotes, profile, other insiders)
29-Aug-144,659,333  Indirect

Insider & restricted shareholder transactions reported over the last two years
DateSharesStockTransaction
13-Jan-16 *500,000ARDX Purchase at $10 per share.
(Cost of $5,000,000)
1-Jan-16 *59,269,000ADAP Statement of Ownership
14-Dec-15 *37,028ECOM Sale at $13.32 per share.
(Proceeds of $493,212)
11-Dec-15 *37,540ECOM Sale at $13.25 per share.
(Proceeds of $497,405)
10-Dec-15 *35,146ECOM Sale at $13.53 per share.
(Proceeds of $475,525)
9-Dec-15 *47,590ECOM Sale at $13.41 per share.
(Proceeds of $638,181)
8-Dec-15 *55,100ECOM Sale at $13.26 per share.
(Proceeds of $730,626)
7-Dec-15 *23,591ECOM Sale at $13.10 per share.
(Proceeds of $309,042)
4-Dec-15 *28,786ECOM Sale at $13.08 per share.
(Proceeds of $376,520)
3-Dec-15 *19,698ECOM Sale at $13.14 per share.
(Proceeds of $258,831)
2-Dec-15 *33,101ECOM Sale at $13.25 per share.
(Proceeds of $438,588)
1-Dec-15 *30,327ECOM Sale at $13.11 per share.
(Proceeds of $397,586)
30-Nov-15 *32,135ECOM Sale at $13.17 per share.
(Proceeds of $423,217)
27-Nov-15 *18,636ECOM Sale at $13.24 per share.
(Proceeds of $246,740)
25-Nov-15 *25,148ECOM Sale at $13.22 per share.
(Proceeds of $332,456)
24-Nov-15 *16,816ECOM Sale at $13.23 per share.
(Proceeds of $222,475)
23-Nov-15 *32,202ECOM Sale at $13.59 per share.
(Proceeds of $437,625)
20-Nov-15 *49,387ECOM Sale at $13.39 per share.
(Proceeds of $661,291)
19-Nov-15 *12,623ECOM Sale at $13.46 per share.
(Proceeds of $169,905)
18-Nov-15 *21,838ECOM Sale at $13.63 per share.
(Proceeds of $297,651)
20-Oct-15 *594,245CERCU Acquisition (Non Open Market)
6-Oct-15 *857,142MIRN Purchase at $7 per share.
(Cost of $5,999,994)
6-Oct-15 *289,166MIRN Acquisition (Non Open Market) at $0 per share.
5-Oct-15 *1,825,209MIRN Acquisition (Non Open Market)
1-Jul-15 12,987ECOM Acquisition (Non Open Market) at $0 per share.
5-Jun-15 *1,869,159ARDX Purchase at $10.70 per share.
(Cost of $20,000,001)
11-Mar-15 *18,750,000CSBR Statement of Ownership
28-Jan-15 *2,091,457BOX Disposition (Non Open Market)
28-Jan-15 *1,928,677BOX Acquisition (Non Open Market)
22-Jan-15 *162,780BOX Statement of Ownership
23-Dec-14 *19,868,965ILIU Purchase at $0.10 per share.
(Cost of $1,986,896)
23-Dec-14 241ARDX Acquisition (Non Open Market) at $0 per share.
23-Dec-14 *10,000ARDX Disposition (Non Open Market) at $0 per share.
29-Aug-14 *11,600SNSS Sale at $7.51 per share.
(Proceeds of $87,116)
28-Aug-14 *146,800SNSS Sale at $7.87 per share.
(Proceeds of $1,155,316)
27-Aug-14 *108,300SNSS Sale at $8.17 per share.
(Proceeds of $884,811)
12-Aug-14 *35,540SNSS Sale at $6.76 per share.
(Proceeds of $240,250)
8-Aug-14 *675,000SNSS Sale at $6.62 per share.
(Proceeds of $4,468,500)
6-Aug-14 *230,769LOXO Purchase at $13 per share.
(Cost of $2,999,997)
6-Aug-14 *1,558,651LOXO Acquisition (Non Open Market)
1-Aug-14 8,680ECOM Acquisition (Non Open Market) at $0 - $25 per share.
22-Jul-14 *2,828,743ROKA Acquisition (Non Open Market)
22-Jul-14 *383,333ROKA Purchase at $12 per share.
(Cost of $4,599,996)
16-Jul-14 *4,734ROKA Statement of Ownership
7-Mar-14 145ECOM Acquisition (Non Open Market) at $0 per share.
7-Mar-14 *606,000ECOM Disposition (Non Open Market) at $0 per share.
7-Mar-14 *6,000ECOM Acquisition (Non Open Market) at $0 per share.
20-Feb-14 *5,800ECOM Acquisition (Non Open Market) at $0 per share.
20-Feb-14 140ECOM Acquisition (Non Open Market) at $0 per share.
20-Feb-14 *585,800ECOM Disposition (Non Open Market) at $0 per share.
10-Feb-14 *585,800ECOM Disposition (Non Open Market) at $0 per share.
10-Feb-14 140ECOM Acquisition (Non Open Market) at $0 per share.
10-Feb-14 *5,800ECOM Acquisition (Non Open Market) at $0 per share.
    * Indicates that some (or all) shares are held indirectly (e.g. in a trust, by a spouse, etc.)



EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search


Copyright © 2016 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Data and information are provided by EDGAR Online, Inc. for informational purposes only and not intended for trading purposes. Yahoo!, EDGAR Online, Inc. shall have no liability for the accuracy of the information furnished or for delays, omissions or opinions expressed therein. You may not use the information for any illegal purpose or furnish the information to any person, firm, or branch office for commercial re-use or re-sale.

Questions or Comments?